Stress in Crohn's Disease
Sponsored by 4YouandMe
About this trial
Last updated 3 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 4 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Diagnosis of Crohn's disease previously established by endoscopy, imaging, and/or histology
* Disease of the small bowel, large bowel, or both large and small bowel
* Needs to have at least one flare in the last 12 months while on current therapy
* Subjects may be on no treatment or may have concurrent treatment with 5-aminosalicylates, antibiotics, corticosteroids, thiopurines, methotrexate or biologic therapies, including infliximab, adalimumab, certolizumab pegol, vedolizumab, or ustekinumab
* Disease level, see stratified enrollment below
* Subjects must have a personal cell phone that is an iPhone SE or newer and be willing to upgrade to the most recent iOS operating system and use their phone for study. This includes a willingness to download and use the study applications and sync their phone with the necessary study devices.
Exclusion Criteria
* Imminent indication for surgery, such as small bowel obstruction or abscess, or surgery in the past 4 weeks
* More than 100 cm of small bowel resected
* Dependence on chronic enteral supplementation or parenteral nutrition or fluids
* Ileostomy or Colostomy (some of the outcome measures do not apply as cannot count # bowel movements)
* History of asymptomatic Crohn's disease for the last 2 years
* Current use of investigational therapy
* Self-reported pregnancy or intent to become pregnant during the study period
